Showing 1291-1300 of 1564 results for "".
- Novartis Implementing Programs to Assist Optometrists During COVID-19https://modernod.com/news/novartis-implementing-programs-to-assist-optometrists-during-covid-19/2477609/Novartis announced that it is implementing the following to ensure optometrists are well-equipped to provide care for patients during the COVID-19 pandemic: Strengthening the online, self-service sample website –
- New Guidance Issued on Paycheck Protection Program Loanshttps://modernod.com/news/new-guidance-issued-on-ppp-loans/2477525/New guidance was posted to the Treasury website regarding the Paycheck Protection Program (PPP), which authorizes up to $349 billion toward job retention and certain other expenses for s
- European Glaucoma Society Postpones Annual Congresshttps://modernod.com/news/european-glaucoma-society-postpones-annual-congress/2477472/The Executive Committee of the European Glaucoma Society has decided to postpone the 14th EGS Congress in Brussels, Belgium to December due to the global COVID-10 pandemic. A statement posted on the EGS website read: “In these times of uncertainty, the first
- Retina Rocks: Retina Image & Reference Library Now Available Onlinehttps://modernod.com/news/retina-rocks-retina-image-reference-library-now-available-online/2477152/Retina Rocks, a new online, collection of open-source retina teachings, is now available at retinarocks.org. The website includes 22,000 multimodal images and 3,700 annotated references that are organized alphabetically by topic into approximately 360 sections
- Researchers Look To Behavior To Explore Why The Coronavirus May Hit Men Harderhttps://modernod.com/news/researchers-look-to-behavior-to-explore-why-the-coronavirus-may-hit-men-harder/2477641/Researchers suspect that the coronavirus is hitting men and women differently. Worldwide, men appear more likely to suffer more severely or die from COVID-19 than women. But experts don’t know why. At Johns Hopkins University, researchers have begun to
- Staar Surgical Announces Leadership Changeshttps://modernod.com/news/staar-surgical-announces-leadership-changes/2482682/Staar Surgical announced that Stephen C. Farrell, current Lead Independent Director of the Staar Board of Directors, has been appointed President and CEO, effective February 26, 2025. He is replacing Tom Frinzi, current President and CEO, who will remain with the company in an advisory role
- iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaginghttps://modernod.com/news/ihealthscreen-awarded-us-patent-on-glaucoma-detection-based-on-ai-and-color-fundus-imaging/2482232/iHealthScreen was awarded a full US patent by USPTO on March 26, 2024 for the iPredict glaucoma detection model. The iPredict is designed to provide a fully automated detection report for glaucoma, which can be implemented in the primary care settings for screening and detecti
- NEI Explores Potential Impacts of Climate Change on Eye Healthhttps://modernod.com/news/nei-explores-potential-impacts-of-climate-change-on-eye-health/2481635/The National Eye Institute (NEI) convened a panel of experts on April 26, 2023, at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) to discuss teye health care needs of the future, including the potential effects of a changing climate on eye health a
- Sifi Announces License Agreement with Avanzanite Bioscience for Acanthamoeba Keratitis Treatment Akantiorhttps://modernod.com/news/sifi-announces-license-agreement-with-avanzanite-bioscience-for-acanthamoeba-keratitis-treatment-akantior/2481340/Italy-based Sifi announced that it has partnered with Avanzanite Bioscience, a Dutch specialty pharmaceutical company, to exclusively commercialize and distribute Akantior (polihexanide) in 26 countries within the European Economic Area and Switzerland. Under the terms of the agreement,
- J&J Vision Presents New Data on Myopia, IOLs, Phacoemulsification, Dry Eye Drops, Vision Science and Refractive Technologieshttps://modernod.com/news/jj-vision-presents-new-data-on-myopia-iols-phacoemulsification-dry-eye-drops-vision-science-and-refractive-technologies-at-arvo/2480839/Johnson & Johnson Vision is presenting 26 poster and podium presentations focusing on myopia, cataract, dry eye, vision science, and refractive research at the Association for Research in Vision and Ophthalmology (ARVO) 2022 Live and Virtual Annual Meeting. Johnson & Johnson Vision poster